STAT3 sustains tumorigenicity following mutant KRAS ablation.

EMBO Rep · 2025 · PMC12549880 · PMID 40859018

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an overall trendno p-value reported

Although both iKRAS and STAT3 KO cells formed tumors when mutant KRAS was turned on, there was an overall trend of higher immune suppression in the iKRAS cancer cells.

also in 3,323 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.